Common questions about Albothyl 1.8% (FAQ)
Q: What Albothyl 1.8% is used for by most people?
Official regulatory documents indicate that the active ingredient, Policresulen, is used to address localized inflammation, infection, and tissue damage, particularly in the vaginal and cervical areas. It is also officially indicated for treating specific anorectal conditions, such as hemorrhoids and fissures.
Q: Is Albothyl 1.8% an antibiotic?
Albothyl 1.8% is formally classified as an antiseptic and disinfectant agent, not a systemic antibiotic. Its mechanism involves a physical-chemical cleansing action that creates an environment hostile to various pathogens, including both bacteria and fungi, at the site of application.
Q: How quickly does Albothyl 1.8% start working after application?
The product's selective action of chemically changing altered tissue begins immediately upon contact. Regulatory product information notes that the discharge of altered tissue shreds is a documented and common side effect that is observed during treatment, which indicates the localized action is occurring.
Q: What is the difference between the gel and the pessaries form of Albothyl (in general terms)?
The active substance Policresulen is available in different topical preparations. Albothyl 1.8% is a hydrophilic gel or jelly, while other products containing Policresulen may be formulated as vaginal suppositories, also called pessaries. These forms differ in their concentration and delivery vehicle, which determines how they are applied locally.
Q: Can I use Albothyl 1.8% if I have an IUD?
The presence of an IUD (intrauterine device) is not listed as an absolute contraindication in official regulatory documents. Some medical information suggests the product has been used for conditions even with an IUD in place. Information regarding use with an IUD is best discussed with a qualified healthcare professional.
Q: How can I tell if Albothyl 1.8% is working?
The discharge of small shreds of mucous membrane is listed in regulatory documents as a Common side effect. This shedding is an expected physiological consequence of the localized therapeutic action, which involves the removal of unhealthy or necrotic tissue.
Q: Does Albothyl 1.8% affect the natural flora of the body?
The product creates a highly acidic local environment. Official scientific information indicates that studies suggest the localized action does not typically affect the normal, beneficial Döderlein bacterial flora (Lactobacillus) of the area.
Q: Is it safe to use Albothyl 1.8% if I am trying to get pregnant?
Official regulatory documents restrict use during pregnancy and lactation. However, there is no specific regulatory data or restriction information available regarding its use during the pre-conception or fertility-planning period.
Q: Is it okay to have sex while using Albothyl 1.8%?
Official instructions consistently advise that sexual intercourse should be avoided during the treatment period. This constraint is also generally advised to continue for up to seven days following the completion of the treatment course.
Q: Why is Albothyl 1.8% sometimes used for minor skin issues?
The active substance, Policresulen, has a primary therapeutic purpose of localized tissue cleansing and conditioning. Some officially recognized formulations of the ingredient are specifically indicated for buccal use as an oral debriding agent to clean minor wounds and inflammation of the mouth and gums.
Q: Are there any long-term studies on the safety of Albothyl 1.8%?
The official research summaries acknowledge that current clinical evidence, while moderate, has limitations. Specifically, the data base for the product includes limited information regarding long-term outcomes and the duration of effects.
Q: What happens if I use Albothyl 1.8% for longer than recommended?
Official guidelines advise that the treatment course should not exceed nine days. Regulatory safety information indicates that extending use beyond the recommended duration may potentially risk disturbing the natural beneficial flora of the mucosa, which could increase the chance of secondary infection.
Q: Is Albothyl 1.8% indicated for use by men for related conditions?
While the gynecological indications apply to women, the regulatory documents also indicate use for conditions related to anorectal pathology, such as hemorrhoids and anal fissures. The product is generally defined for use in adult populations for these specific localized conditions.
Q: Does the 1.8% concentration refer to the active ingredient strength?
Yes, regulatory documents confirm this. The 1.8% figure specifically refers to the concentration of the sole active ingredient, Policresulen, within the hydrophilic gel or vaginal jelly formulation.
Q: Are there any foods or drinks to avoid while using Albothyl 1.8%?
The official regulatory Interaction Map and statements document no known interactions or contraindications related to the consumption of any specific foods or drinks while using the product.
Q: Is Albothyl 1.8% used for cervical issues?
Yes. Official regulatory documentation explicitly indicates that the product is appropriate for localized inflammation, infection, and tissue damage of both the vagina and the cervix.
Q: Do regulatory documents note the potential for allergic reactions to Albothyl 1.8%?
Yes, the official safety labeling recognizes the potential for systemic effects, including various forms of allergic reactions. These range from localized itching and hives to more serious reactions like angioedema (swelling) and, rarely, anaphylaxis.
Q: Can Albothyl 1.8% be used to treat yeast infections?
The mechanism involves a broad-spectrum cleansing action effective against various pathogens, including fungi such as Candida. Regulatory indications include treatment for secretions and infections caused by these organisms.
Q: What if I experience a side effect not listed on the package?
If any reaction occurs that is not listed in the product information, consultation with a healthcare professional is generally advised. The healthcare professional can provide guidance on reporting the event to the national regulatory agency.
Q: What is the shelf life or expiration date for Albothyl 1.8%?
The expiration date printed on the packaging defines the product's official shelf life. This is the period during which the medicine is guaranteed by the manufacturer to remain effective, safe, and stable, provided it has been stored according to the specified conditions.
Q: Is it true that Albothyl 1.8% can be used for dental/oral issues?
Yes, some officially recognized formulations of the active ingredient Policresulen are specifically indicated for buccal use (in the mouth). This use is primarily as an oral debriding agent to cleanse canker sores, minor wounds, or general gum inflammation.
Q: Can Albothyl 1.8% be used for non-infectious conditions?
Yes. The regulatory indications for the product include treatment for generalized localized tissue damage and certain inflammatory lesions that may be non-infectious in nature. The mechanism focuses on removing damaged tissue and promoting regeneration.
Q: Is Albothyl 1.8% effective against all types of bacteria?
The product is characterized by a broad-spectrum cleansing action, meaning it is active against a wide variety of common Gram-positive and Gram-negative bacteria, as well as fungi. However, official information does not confirm its efficacy against all bacterial species.
Q: Does the effectiveness of Albothyl 1.8% change with the time of day it's used?
The official instructions mandate application at night before going to sleep. This scheduling is primarily intended to facilitate retention of the product when lying down, which maximizes the duration of its localized action rather than affecting the inherent potency of the ingredient itself.
